MedTrace Logo

Mater-Bronx Rapid HIV Testing Project.

NCT01778374 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17000

Last updated 2020-03-25

No results posted yet for this study

Summary

In the M-BRiHT study we aim to implement a programme of opportunistic HIV screening in the Emergency Department, Mater Misericordiae University Hospital. We hypothesize that such a programme will be acceptable in an Irish setting. We also wish to study the factors that influence test completion or acceptance. We will utilise informative interactive video media via a touch-screen tablet device to provide pre-test counselling and then offer rapid minimally invasive testing with a cotton-bud type swab of the buccal mucosa. In doing so we will to determine absolute numbers of those attending the ED who consent to watching the interactive information video about rapid HIV test screening. We will describe the absolute number and proportion of those who watch the interactive video who subsequently proceed to have the rapid HIV test. The primary aim is to determine the cultural, gender and ethnic factors which influence the completion of such rapid HIV testing with the future objective of maximising test completion in this crucial public health area.

Conditions

  • Human Immunodeficiency Virus

Interventions

OTHER

No participant choice of counselor

Participants in this arm of the study are randomized to an interactive video counselor with no choice of counselor. This is delivered via a touchscreen tablet device.

OTHER

Participant choice of counselor

Participants in this arm of the study are randomized to an interactive video counselor with a choice of four different counselors. These gender and ethnically diverse counselors are delivered via a touchscreen tablet device.

Sponsors & Collaborators

  • University College Dublin

    lead OTHER

Principal Investigators

  • Patrick WG Mallon, MB, BCh, BAO, FRACP, FRCPI,PhD · Group Leader, HIV Molecular Research Group, University College Dublin

  • Gerard S O'Connor, MB, BCh, BAO, MCEM, MMed · Project Lead M-BRiHT, HIV Molecular Research Group, University College Dublin.

  • Yvette Calderon, MD · Jacobi Medical Centre, New York

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2020-07-31
Completion
2020-12-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01778374 on ClinicalTrials.gov